LGALS4 and ulcerative colitis: Galectin-4 differs from other galectins in carbohydrate-binding specificity, cellular and pathophysiological function, and roles in e.g. cancer progression, fibrosis, and ulcerative colitis, making potent, selective inhibitors desired.